Eurocine Vaccines and Redbiotec have signed a research and collaboration agreement for the development of vaccine candidates against herpes simplex virus type 2. Under the terms of the agreement, Eurocine will have exclusive international rights to
Tags :Redbiotec
Redbiotec, a Swiss developer of a therapeutic vaccine for genital herpes, plans to close CHF 9m Series A round this year